Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Avorn

Showing results (11-20 of 184) with videos related to

Pageof 19
Sort By:
International Journal of Technology Assessment in Health Care|January 1, 1995
The prescription as final common pathwayJ Avorn
Epidemiology (Cambridge, Mass.)|March 1, 1990
Medicaid-based pharmacoepidemiology: claims and counterclaimsJ Avorn
American Journal of Public Health|January 1, 1995
Drug regulation and drug information--who should do what to whom?J Avorn
BMJ (Clinical Research Ed.)|November 21, 1997
Including elderly people in clinical trialsJ Avorn
Clinical Pharmacology and Therapeutics|December 1, 1987
Pharmacology and geriatric practice: a case study in technology nontransferJ Avorn
Pharmacoeconomics|December 8, 1997
Healthcare and the tooth fairy. A merger that won't result in 'smarter' medicineJ Avorn
The New England Journal of Medicine|September 24, 1981
Nursing-home infections - the contextJ Avorn
Journal of Clinical Epidemiology|January 1, 1991
Epidemiology in Plato's cave: claims data and clinical realityJ Avorn
JAMA|December 12, 2001
Improving drug use in elderly patients: getting to the next levelJ Avorn
Pharmacoeconomics|January 11, 2001
Post-modern drug evaluation. The deconstruction of evidence-based regulationJ Avorn
Pageof 19

Showing results (11-20 of 184) with videos related to

Sort By:
Pageof 19
International Journal of Technology Assessment in Health Care|January 1, 1995
The prescription as final common pathwayJ Avorn
Epidemiology (Cambridge, Mass.)|March 1, 1990
Medicaid-based pharmacoepidemiology: claims and counterclaimsJ Avorn
American Journal of Public Health|January 1, 1995
Drug regulation and drug information--who should do what to whom?J Avorn
BMJ (Clinical Research Ed.)|November 21, 1997
Including elderly people in clinical trialsJ Avorn
Clinical Pharmacology and Therapeutics|December 1, 1987
Pharmacology and geriatric practice: a case study in technology nontransferJ Avorn
Pharmacoeconomics|December 8, 1997
Healthcare and the tooth fairy. A merger that won't result in 'smarter' medicineJ Avorn
The New England Journal of Medicine|September 24, 1981
Nursing-home infections - the contextJ Avorn
Journal of Clinical Epidemiology|January 1, 1991
Epidemiology in Plato's cave: claims data and clinical realityJ Avorn
JAMA|December 12, 2001
Improving drug use in elderly patients: getting to the next levelJ Avorn
Pharmacoeconomics|January 11, 2001
Post-modern drug evaluation. The deconstruction of evidence-based regulationJ Avorn
Pageof 19